28 April 2026 BRC Therapeutics Announces Investigational New Drug Application for BRC-002 Cleared by FDA » Full release
6 January 2026 BRC Therapeutics Announces Peer-Reviewed Publication on Navigating Drug Development Pathways for Botanical Cannabinoid Medicines » Full release